GEN Information

Contact top employees from GEN

Summary

GEN is the leading speciality pharmaceutical company in Türkiye, with more than 25 years of experience.
GEN is actively working in both business models of in-licensing and out-licensing. We part...Show more

Organization Website

genilac.com.tr

Social Links

linkedIn

Phone Number

0 312 219 62 19

Industries

Headquarters Location

Mustafa Kemal, 2131. Sk. No:15, 06520, Ankara, Çankaya, 06520 TR

Employees Size

500-1000 employees

Specialties

Orphan drugs, Rare diseases, Innovative treatment alternatives for various disorders, Endocrinology, Neurology, Nephrology, Metabolism Disorders, Nadir Hastalıklar, NPP, Yetim İlaç, Onkoloji, Hematoloji, Nöroloji, Nefroloji, Oncology, Hematology, Pediatry, Production, Yerli Üretim

Founded

1998

Employees Turnover 4 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Number of employees by department
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at GEN shows a diverse range of experience levels:
3% have been with the company for less than 1 year30% for 1–2 years28% for 3–4 years15% for 5–7 years9% for 8–10 years15% have over 11 years of service at GEN
Ex-employees positions
In Company
In New Company
Contact top employees from GEN

FAQ

GEN operates in the Pharma industries. More details can be found on the official website: genilac.com.tr.
The headquarters of GEN are located in Ankara, Turkey.
You can contact GEN by phone at 0 312 219 62 19.
GEN currently employs 500-1000 people.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP